Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fenofibrate Intervention and Event Lowering in Diabetes.

Trial Profile

Fenofibrate Intervention and Event Lowering in Diabetes.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jul 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fenofibrate (Primary)
  • Indications Cardiovascular disorders; Coronary disorders; Diabetic complications; Diabetic retinopathy; Myocardial infarction; Stroke
  • Focus Therapeutic Use
  • Acronyms FIELD
  • Sponsors Fournier Pharma
  • Most Recent Events

    • 01 Jul 2023 Results of a post-hoc analysis assessing association between diabetic microvascular complications with bone fragility using data from this trial published in the Diabetes/Metabolism Research and Reviews
    • 01 Apr 2022 Results (n=208) published in the Internal Medicine Journal
    • 30 Mar 2020 Results exploring associations between lipoprotein subfractions and apoproteins and risk for ischemic stroke in the FIELD trial presented at the 2020 Annual Scientific Session of the American College of Cardiology and World Congress of Cardiology
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top